BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
Conditions: Bronchiolitis Obliterans Syndrome; Bronchiolitis Obliterans; Lung Diseases; Chronic Graft Versus Host Disease Interventions: Drug: Belumosudil; Drug: Fluticasone; Drug: Azithromycin; Drug: Prednisone Sponsors: Dana-Farber Cancer Institute; Sanofi; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Azithromycin | Bronchiolitis | Cancer & Oncology | Cardiology | Flonase | Heart | Prednisone | Research | Zithromax